Marcela Viviana Karpuj

Prof. Marcela Viviana Karpuj

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
Marcela Viviana KarpujMarcela Viviana Karpuj
Marcela Viviana Karpuj
KGKurt Giles
Kurt Giles
SGSagit Gelibter-Niv
Sagit Gelibter-Niv
MSMichael R. Scott
Michael R. Scott
Vishwanath LingappaVishwanath Lingappa
Vishwanath Lingappa
SPStanley B. Prusiner
Stanley B. Prusiner
Prions are composed solely of the disease-causing prion protein (PrPSc) that is formed from the cellular isoform PrPC by a post-translational process. Here we report that short phosphorothioate DNA (PS-DNA) oligonucleotides diminished the levels of both PrPC and PrPSc in prion-infected neuroblastoma (ScN2a) cells. The effect of PS-DNA on PrP levels was independent of the nucleotide sequence. The effective concentration (EC50) of PS-DNA required to achieve half-maximal diminution of PrPSc was ~70 nM, whereas the EC50 of PS-DNA for PrPC was more than 50-fold greater. This finding indicated that diminished levels of PrPSc after exposure to PS-DNA are unlikely to be due to decreased PrPC levels. Bioassays in transgenic mice demonstrated a substantial diminution in the prion infectivity after ScN2a cells were exposed to PS-DNAs. Whether PS-DNA will be useful in the treatment of prion disease in people or livestock remains to be established.

10 March 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
LGLihi Grinberg
Lihi Grinberg
FAFadwa Dabbah Assadi
Fadwa Dabbah Assadi
GBGideon Baum
Gideon Baum
RZRomy Zemel
Romy Zemel
RTRan Tur-Kaspa
Ran Tur-Kaspa
Marcela Viviana KarpujMarcela Viviana Karpuj
Marcela Viviana Karpuj
A major cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma, non-alcoholic fatty liver disease (NAFLD) results from excessive liver fat accumulation. Vitamin D (VitD) plays multiple important roles in diverse physiologic processes. Here, we describe the role of VitD in the complex pathogenesis of NAFLD and explore the possible therapeutic role of VitD supplementation in NAFLD therapy. To compare the effect of VitD to other interventions such as low-calorie diet, we induced NAFLD in young adult zebrafish (Danio rerio, AB strain) and monitored the effects of VitD supplementation on the disease course. The zebrafish administered with high-dose VitD (1.25 μg) had significantly reduced liver fat compared to those that received low-dose VitD (0.049 μg) or caloric restriction. Gene expression analysis revealed that VitD downregulated several pathways that may play a role in NAFLD etiology, which affected fatty acid metabolism, vitamins and their cofactors, ethanol oxidation, and glycolysis. The pathway analysis revealed that the cholesterol biosynthesis pathway and the isoprenoid biosynthetic process pathway were significantly upregulated whereas the small molecule catabolic process pathway significantly downregulated following the exposure of NAFLD zebrafish model to high VitD dose. Therefore, our findings suggest the association of novel biochemical pathways with NAFLD and highlight the potential of VitD supplementation to reverse the severity of NAFLD, especially in younger people.

1 March 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Marcela Viviana KarpujMarcela Viviana Karpuj
Marcela Viviana Karpuj
SGSagit Gelibter-Niv
Sagit Gelibter-Niv
ATAnat Tiran
Anat Tiran
ARAngelika Rambold
Angelika Rambold
JTJorg Tatzelt
Jorg Tatzelt
HSHermann Schatzl
Hermann Schatzl
We demonstrate that the levels of native as well as transfected prion protein (PrP) are lowered in various cell lines exposed to phosphorothioate oligodeoxynucleotides (PS-DNA) and can be rapidly reverted to their normal amounts by removal of PS-DNA. This transient modulation was independent of the glycosylation state of PrP, and in addition, all three PrP glycoforms were susceptible to PS-DNA treatment. Deletion of the N-terminal domain (amino acids 23-99), but not of the other domains of PrP, abrogated its PS-DNA-mediated down-regulation. PrP versions localized in the mitochondria, cytoplasm, or nucleus were not modulated by PS-DNA, indicating that PrP surface exposure is required for executing this effect. Proteins that in their native forms were not responsive to PS-DNA, such as thymocyte antigen 1 (Thy1), Doppel protein (Dpl), green fluorescent protein (GFP), and cyan fluorescent protein (CFP), became susceptible to PS-DNA-mediated down-regulation following introduction of the N terminus of PrP into their sequence. These observations demonstrate the essential role of the N-terminal domain for promoting oligonucleotide-mediated reduction of the PrP level and suggest that transient treatment of cultured cells with PS-DNA may provide a general method for targeted modulation of the levels of desired surface proteins in a conditional and reversible manner.

Verified
Journal Article
Open access
PDF file
Marcela Viviana KarpujMarcela Viviana Karpuj
Marcela Viviana Karpuj
DSD. R. Shaytov
D. R. Shaytov
YAYonat Shemer Avni
Yonat Shemer Avni
MGMichael Gideon
Michael Gideon
ZFZakharia M. Frenkel
Zakharia M. Frenkel
Sarit Sara SivanSarit Sara Sivan
Sarit Sara Sivan
In the face of the SARS-CoV-2 pandemic, characterized by the virus’s rapid mutation rates, developing timely and targeted therapeutic and diagnostic interventions presents a significant challenge. This study utilizes bioinformatic analyses to pinpoint conserved genomic regions within SARS-CoV-2, offering a strategic advantage in the fight against this and future pathogens. Our approach has enabled the creation of a diagnostic assay that is not only rapid, reliable, and cost-effective but also possesses a remarkable capacity to detect a wide array of current and prospective variants with unmatched precision. The significance of our findings lies in the demonstration that focusing on these conserved genomic sequences can significantly enhance our preparedness for and response to emerging infectious diseases. By providing a blueprint for the development of versatile diagnostic tools and therapeutics, this research paves the way for a more effective global pandemic response strategy.